Almac Increases Cold and Frozen Storage

Almac’s Pharma Services business has expanded its commercial facility by adding increased storage capacity for biologic products. The company has experienced increased client demand for cold and dedicated frozen storage capacity for biopharmaceuticals, so it added an additional 6124 sq ft of cold and frozen storage.
 
This is a joint investment with a commercial client, for which Almac provides central EU importation, warehousing, and distribution services. It includes dedicated -70°C, -20°C, and 2-8°C storage for drug antibody, drug linker, bulk drug substance, placebo, and filled vials, coupled to before and after distribution to various global processing facilities. Twenty additional dedicated freezer units have been added to the existing ten, for the storage of the monoclonal antibody and bulk drug substance products.
 
The expansion has also resulted in increased floor space facilitating shipping system configuration for bulk drug product and for direct to pharmacy supply of niche orphan drug products.
 
According to David Downey, Vice President, Commercial Operations, “It is a pleasure to be able to expand our scope of services through this shared investment. Our ability to ensure all necessary preparations are made for this important commercial launch, positions Almac well within this growing biopharmaceutical sector.”